SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-08-231698
Filing Date
2008-11-10
Accepted
2008-11-10 16:06:51
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d10qa.htm 10-Q/A 17609
2 THIRD AMENDED AND RESTATED BY-LAWS OF ANTIGENICS INC. dex32.htm EX-3.2 59912
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 2968
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 2918
5 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 4495
  Complete submission text file 0001193125-08-231698.txt   89320
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-29089 | Film No.: 081175704
SIC: 2836 Biological Products, (No Diagnostic Substances)